These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 34943191)

  • 1. A Conservative Replacement in the Transmembrane Domain of SARS-CoV-2 ORF7a as a Putative Risk Factor in COVID-19.
    Lobiuc A; Șterbuleac D; Sturdza O; Dimian M; Covasa M
    Biology (Basel); 2021 Dec; 10(12):. PubMed ID: 34943191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding how transmembrane domains regulate interactions between human BST-2 and the SARS-CoV-2 accessory protein ORF7a.
    Mann MM; Hsieh MK; Tang JD; Hart WS; Lazzara MJ; Klauda JB; Berger BW
    Biochim Biophys Acta Biomembr; 2023 Aug; 1865(6):184174. PubMed ID: 37211321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal-Geographical Dispersion of SARS-CoV-2 Spike Glycoprotein Variant Lineages and Their Functional Prediction Using
    Boon SS; Xia C; Wang MH; Yip KL; Luk HY; Li S; Ng RWY; Lai CKC; Chan PKS; Chen Z
    mBio; 2021 Oct; 12(5):e0268721. PubMed ID: 34700382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus.
    Kim YJ; Jang US; Soh SM; Lee JY; Lee HR
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33917138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitination of SARS-CoV-2 ORF7a Prevents Cell Death Induced by Recruiting BclXL To Activate ER Stress.
    Liu Z; Fu Y; Huang Y; Zeng F; Rao J; Xiao X; Sun X; Jin H; Li J; Yang J; Du W; Liu L
    Microbiol Spectr; 2022 Dec; 10(6):e0150922. PubMed ID: 36326498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.
    Pyke AT; Nair N; van den Hurk AF; Burtonclay P; Nguyen S; Barcelon J; Kistler C; Schlebusch S; McMahon J; Moore F
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational decomposition reveals reshaping of the SARS-CoV-2-ACE2 interface among viral variants expressing the N501Y mutation.
    Socher E; Conrad M; Heger L; Paulsen F; Sticht H; Zunke F; Arnold P
    J Cell Biochem; 2021 Dec; 122(12):1863-1872. PubMed ID: 34516024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein.
    Liu J; Chen X; Liu Y; Lin J; Shen J; Zhang H; Yin J; Pu R; Ding Y; Cao G
    Infect Dis Poverty; 2021 Aug; 10(1):112. PubMed ID: 34419160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
    Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
    Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 ORF7a blocked autophagy flux by intervening in the fusion between autophagosome and lysosome to promote viral infection and pathogenesis.
    Li S; Li X; Liang H; Yu K; Zhai J; Xue M; Luo Z; Zheng C; Zhang H
    J Med Virol; 2023 Nov; 95(11):e29200. PubMed ID: 37916857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging SARS-CoV-2 variants of concern.
    Sanyaolu A; Okorie C; Marinkovic A; Haider N; Abbasi AF; Jaferi U; Prakash S; Balendra V
    Ther Adv Infect Dis; 2021; 8():20499361211024372. PubMed ID: 34211709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into the LFA-1/SARS-CoV-2 Orf7a Complex by Protein-Protein Docking, Molecular Dynamics, and MM-GBSA Calculations.
    Ongaro A; Oselladore E; Memo M; Ribaudo G; Gianoncelli A
    J Chem Inf Model; 2021 Jun; 61(6):2780-2787. PubMed ID: 34043356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection Efficiency.
    Alaofi AL; Shahid M
    Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Interaction between E484K and N501Y Substitutions of SARS-CoV-2 in Shaping the Transmission Advantage of COVID-19 in Brazil: A Modeling Study.
    Zhao S; Ran J; Han L
    Am J Trop Med Hyg; 2021 Sep; 105(5):1247-1254. PubMed ID: 34583340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to downregulate MHC-I surface expression.
    Arshad N; Laurent-Rolle M; Ahmed WS; Hsu JC; Mitchell SM; Pawlak J; Sengupta D; Biswas KH; Cresswell P
    bioRxiv; 2022 May; ():. PubMed ID: 35611331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H.
    Zeng C; Evans JP; Faraone JN; Qu P; Zheng YM; Saif L; Oltz EM; Lozanski G; Gumina RJ; Liu SL
    mBio; 2021 Oct; 12(5):e0251021. PubMed ID: 34607452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of antiviral immune response and disruption of cellular functions by SARS-CoV-2 ORF7a and ORF7b.
    García-García T; Fernández-Rodríguez R; Redondo N; de Lucas-Rius A; Zaldívar-López S; López-Ayllón BD; Suárez-Cárdenas JM; Jiménez-Marín Á; Montoya M; Garrido JJ
    iScience; 2022 Nov; 25(11):105444. PubMed ID: 36310646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants.
    Vesper N; Ortiz Y; Bartels-Burgahn F; Yang J; de la Rosa K; Tenbusch M; Schulz S; Finzel S; Jäck HM; Eibel H; Voll RE; Reth M
    Front Immunol; 2021; 12():730766. PubMed ID: 34630410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.